Company intelligence / Profile preview

Diagnostic Photonics

Chicago, Illinois, United Statesmedtechinnovator.org ↗

Ownership: Private
Development stage: Commercial

Overview

The Foresee™ Imaging System provides surgeons with real-time microscopic information about disease extent during surgery, potentially reducing repeat procedures and improving outcomes. The company has demonstrated progress toward market adoption and has won innovation awards. Clinical results are not detailed in public sources but the technology aims to improve accuracy and speed of intraoperative decision-making in oncology surgeries such as breast cancer.

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: Device
Industry: Pathology

Partnerships

PROPEL Center/iBIO Institutes PROPEL program partnership/supporter

Beyond the preview

Go deeper on Diagnostic Photonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnostic Photonics.

Explore the full profile